190 related articles for article (PubMed ID: 30309319)
1. Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells.
Song X; Guo C; Zheng Y; Wang Y; Jin Z; Yin Y
BMC Cancer; 2018 Oct; 18(1):971. PubMed ID: 30309319
[TBL] [Abstract][Full Text] [Related]
2. The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling.
Song X; Hao J; Wang J; Guo C; Wang Y; He Q; Tang H; Qin X; Li Y; Zhang Y; Yin Y
Oncogene; 2017 Mar; 36(11):1476-1486. PubMed ID: 27775077
[TBL] [Abstract][Full Text] [Related]
3. Cancer‑testis antigen HCA587/MAGEC2 interacts with the general transcription coactivator TAF9 in cancer cells.
Zeng P; Wang Y; Zheng Y; Song X; Yin Y
Mol Med Rep; 2018 Feb; 17(2):3226-3231. PubMed ID: 29257297
[TBL] [Abstract][Full Text] [Related]
4. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
[TBL] [Abstract][Full Text] [Related]
5. MageC2 protein is upregulated by oncogenic activation of MAPK pathway and causes impairment of the p53 transactivation function.
Pascucci FA; Ladelfa MF; Toledo MF; Escalada M; Suberbordes M; Monte M
Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118918. PubMed ID: 33279609
[TBL] [Abstract][Full Text] [Related]
6. Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells.
Wang J; Song X; Guo C; Wang Y; Yin Y
Cancer Sci; 2016 Dec; 107(12):1888-1897. PubMed ID: 27636589
[TBL] [Abstract][Full Text] [Related]
7. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
8. Expression of cancer-testis antigens in hepatocellular carcinoma.
Zhao L; Mou DC; Leng XS; Peng JR; Wang WX; Huang L; Li S; Zhu JY
World J Gastroenterol; 2004 Jul; 10(14):2034-8. PubMed ID: 15237429
[TBL] [Abstract][Full Text] [Related]
9. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.
Yang F; Zhou X; Miao X; Zhang T; Hang X; Tie R; Liu N; Tian F; Wang F; Yuan J
Breast Cancer Res Treat; 2014 May; 145(1):23-32. PubMed ID: 24687377
[TBL] [Abstract][Full Text] [Related]
10. Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma.
Lajmi N; Luetkens T; Yousef S; Templin J; Cao Y; Hildebrandt Y; Bartels K; Kröger N; Atanackovic D
Br J Haematol; 2015 Dec; 171(5):752-62. PubMed ID: 26456863
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of TRIM28 inhibits growth and increases apoptosis of nude mice with non‑small cell lung cancer xenografts.
Liu L; Zhang L; Wang J; Zhao X; Xu Q; Lu Y; Zuo Y; Chen L; Du J; Lian Y; Zhang Q
Mol Med Rep; 2018 Jan; 17(1):835-842. PubMed ID: 29115614
[TBL] [Abstract][Full Text] [Related]
12. Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma.
Han J; Wang Y; Zhou H; Ai S; Wan D
Comput Math Methods Med; 2022; 2022():6267851. PubMed ID: 36238495
[TBL] [Abstract][Full Text] [Related]
13. The complexity of TRIM28 contribution to cancer.
Czerwińska P; Mazurek S; Wiznerowicz M
J Biomed Sci; 2017 Aug; 24(1):63. PubMed ID: 28851455
[TBL] [Abstract][Full Text] [Related]
14. Generation of TRIM28 Knockout K562 Cells by CRISPR/Cas9 Genome Editing and Characterization of TRIM28-Regulated Gene Expression in Cell Proliferation and Hemoglobin Beta Subunits.
Chang YJ; Kang Z; Bei J; Chou SJ; Lu MJ; Su YL; Lin SW; Wang HH; Lin S; Chang CJ
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743282
[TBL] [Abstract][Full Text] [Related]
15. TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.
Li F; Wang Z; Lu G
Oncol Rep; 2018 Apr; 39(4):1860-1866. PubMed ID: 29393469
[TBL] [Abstract][Full Text] [Related]
16. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment.
Park HH; Kim HR; Park SY; Hwang SM; Hong SM; Park S; Kang HC; Morgan MJ; Cha JH; Lee D; Roe JS; Kim YS
Mol Cancer; 2021 Aug; 20(1):107. PubMed ID: 34419074
[TBL] [Abstract][Full Text] [Related]
17. Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment.
Fitzgerald S; Espina V; Liotta L; Sheehan KM; O'Grady A; Cummins R; O'Kennedy R; Kay EW; Kijanka GS
J Transl Med; 2018 Apr; 16(1):89. PubMed ID: 29631612
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of TRIM28 Enhances the Expression of IFN-β and Proinflammatory Cytokines During HPAIV Infection of Human Lung Epithelial Cells.
Krischuns T; Günl F; Henschel L; Binder M; Willemsen J; Schloer S; Rescher U; Gerlt V; Zimmer G; Nordhoff C; Ludwig S; Brunotte L
Front Immunol; 2018; 9():2229. PubMed ID: 30323812
[TBL] [Abstract][Full Text] [Related]
19. Gain of LINC00624 Enhances Liver Cancer Progression by Disrupting the Histone Deacetylase 6/Tripartite Motif Containing 28/Zinc Finger Protein 354C Corepressor Complex.
Li Z; Lu X; Liu Y; Zhao J; Ma S; Yin H; Huang S; Zhao Y; He X
Hepatology; 2021 May; 73(5):1764-1782. PubMed ID: 32869873
[TBL] [Abstract][Full Text] [Related]
20. TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.
Lionnard L; Duc P; Brennan MS; Kueh AJ; Pal M; Guardia F; Mojsa B; Damiano MA; Mora S; Lassot I; Ravichandran R; Cochet C; Aouacheria A; Potts PR; Herold MJ; Desagher S; Kucharczak J
Cell Death Differ; 2019 May; 26(5):902-917. PubMed ID: 30042493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
